Get the Stockscreener App
1.01
3.81%
-0.04
After Hours:
1.05
0.04
+3.96%
Pluri Inc stock is traded at $1.01, with a volume of 5,056.
It is down -3.81% in the last 24 hours and down -39.16% over the past month.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
See More
Previous Close:
$1.05
Open:
$1.1319
24h Volume:
5,056
Relative Volume:
0.17
Market Cap:
$12.47M
Revenue:
$1.08M
Net Income/Loss:
$-26.95M
P/E Ratio:
-0.3518
EPS:
-2.8712
Net Cash Flow:
$-21.69M
1W Performance:
-6.48%
1M Performance:
-39.16%
6M Performance:
-69.67%
1Y Performance:
-77.74%
1-Day Range:
$1.01
$1.1599
1-Week Range:
$0.98
$1.1599
52-Week Range:
$0.98
$4.865
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
1.01 | 12.47M | 1.08M | -26.95M | -21.69M | -2.8712 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pluri Inc Stock (PLUR) Latest News
Pluri Inc. (PLUR) Key Financial Ratios – Valuation, Profitability & More - Value Research
Pluri (NASDAQ: PLUR) preps $200M shelf for future stock and warrant offerings - Stock Titan
Pluri: Fiscal Q4 Earnings Snapshot - marketscreener.com
Pluri Inc. FY 2026: Revenue $1.02M, EPS $(2.44) — 10-K Summary - TradingView
Pluri Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
Pluri Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Pluri Inc. (NASDAQ: PLUR) Share Price, PLUR Stock News, PLUR Share Price & Updates - Kalkine
Pluri Inc. (PLUR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Pluri (PLUR) turns to private warrants for funding - Stock Titan
Insiders' US$14.6m Investments In Red Following Pluri's US$2.2m Dip In Market Value - simplywall.st
Pluri Inc. (PLUR) Peer Comparison – Compare with Others - Value Research
Pluri Inc. (NASDAQ: PLUR) Announces $1.50 Share Sale with 2.23M Pre-Funded Warrants in Direct Offering - kalkinemedia.com
Pluri Announces August 2026 Equity Financing Transaction - The Globe and Mail
Pluri Inc. (PLUR) Edges Higher Above $1.46 Support as Consolidation ContinuesTick Index - dars.gov.et
Pluri Raises ~$3.0M in Registered Direct Offering With 5-Year Warrants; AGP Named Placement Agent - TradingView
Pluri raises $3.3 million in registered direct offering By Investing.com - Investing.com South Africa
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor - Yahoo Finance
Pluri (PLUR) director's 31,569-share grant vests over 3 years - Stock Titan
Pluri Inc. (PLUR) insider logs stock trades in new SEC filing - Stock Titan
Pluri (PLUR) Results at a Glance: The EPS Result Is Below Expectation; Trading Response: Shares Finish 0.57% UpQuarterly Earnings Report - vinanet.vn
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Pluri Subsidiary to Acquire Fishway BV, Diluting Pluri Stake to 58% - Minichart
Pluri Subsidiary Acquires Fishway to Expand Cultivated Seafood - TipRanks
Pluri Inc. (PLUR) Holds at $1.75 as Traders Eye Key Support and ResistanceBull Pennant - Vinanet
PLUR Q2 2026 Earnings: Wider-Than-Expected Loss Reflects Continued Investment in Cell Therapy PipelineLong-Term Guidance - vinanet.vn
Pluri Inc. Revenue Breakdown – NASDAQ:PLUR - TradingView
Pluri Inc (PLUR) Stock News Today - TradingKey
Pluri Inc (PLUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PLUR Q2 2026 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage InvestmentEarnings Surprise Stocks - dars.gov.et
PLUR Q2 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue Investment CostsNet Profit Margin - careplusvn.com
Pluri Inc (PLUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cellav Health and Aesthetics Ltd Completes Regulatory Registration of Regenativo+ in the UK - marketscreener.com
Pluri's subsidiary Cellav completes UK regulato... - Pluang
Pluri subsidiary completes UK regulatory registration for aesthetics product - Investing.com
Pluri’s Regenativo+ Is Registered for Sale in a $900M UK Market - Stock Titan
Pluri Inc (PLUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pluri Inc. (PLUR) Gains Slightly as Stock Tests Key Resistance Near $1.76Ichimoku Kumo Break - careplusvn.com
Pluri Inc (PLUR) Balance Sheet - TradingKey
PLUR|Pluri Inc|Price:1.550|Chg%:-0.010 - TradingKey
Pluri Inc (PLUR) Cash Flow - TradingKey
Pluri Inc (PLUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PLUR|Pluri Inc|Price:1.640| - TradingKey
Pluri Inc (PLUR) Earnings Date & Reports & Earnings News - TradingKey
Pluri Inc (PLUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pluri Inc (PLUR) Institutional Confidence - TradingKey
PLUR|Pluri Inc|Price:1.780|Chg%:-0.040 - TradingKey
Pluri Inc. (PLUR) Q2 2026 Earnings: EPS Miss Adds to Market Concerns as Pre-Revenue Status Continues - dars.gov.et
Pluri Inc (PLUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pluri Inc (PLUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Enterprise value to revenue forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):